TY  - JOUR
AU  - Alcaraz Sanabria, Ana
AU  - Cabañas Morafraile, Esther
AU  - Fernández Hinojal, Gonzalo
AU  - Velasco Díez, Guillermo
AU  - Pérez Segura, Pedro
AU  - Pandiella, Atanasio
AU  - Györffy, Balázs
AU  - Ocaña, Alberto
PY  - 2022
DO  - 10.3389/fimmu.2021.786069
SN  - 1664-3224
UR  - https://hdl.handle.net/20.500.14352/71804
T2  - Frontiers in Immunology
AB  - Targeting K-RAS-mutant non-small cell lung cancer (NSCLC) with novel inhibitors has shown promising results with the recent approval of sotorasib in this indication. However, progression to this agent is expected, as it has previously been observed...
LA  - eng
M2  - 1
PB  - Frontiers Media
KW  - K-RAS
KW  - Lung adenocarcinoma
KW  - Surfaceome
KW  - Genomic signature
KW  - CLDN10 and TMPRSS6
TI  - Transcriptomic mapping of non-small cell lung cancer K-RAS p.G12C mutated tumors: identification of surfaceome targets and immunologic morrelates
TY  - journal article
VL  - 12
ER  -